ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

Three Venerable Acronyms Fade Away As Cooperative Groups Form “Alliance”

June 17, 2011

Frank Torti Named FDA Deputy Commissioner, To Take Leave As Wake Forest Center Director.

April 11, 2008

U.S., France Offer Carcinogenesis Program

February 13, 1981

In Brief: Robert Bast Succeeds Singleton As Director Of Duke Cancer Center; Robert Bell Deputy

August 14, 1987

The Duke Scandal: NEJM Retracts Potti Paper

March 4, 2011

Researchers Identify Five Genes Associated With Melanoma Risk

July 29, 2011